Alejandro Adolfo M. B.
- Country
- Spain
- Department
- 034-03: Oncology
Research Overview
Data & Insights
Has run more than one trial at 184 of 438 partner sites.
Specializations
Breast Cancer Research
The investigator specializes in treating various forms of breast cancer, with particular focus on hormone receptor-positive (HR+) and HER2-positive breast cancer. Their research encompasses both early-stage and metastatic disease management.
- Triple-negative breast cancer (TNBC)
- Advanced/metastatic breast cancer treatment
- Neoadjuvant therapy approaches
The investigator works with novel therapeutic agents including endocrine therapies and targeted antibody-drug conjugates.
Gynecologic Oncology
Focus areas include the treatment of advanced ovarian cancer, fallopian tube cancer, and peritoneal cancer. The investigator has expertise in both primary and recurrent disease settings.
- Platinum-sensitive ovarian cancer
- Folate receptor-alpha targeted therapy
- Maintenance treatment strategies
Research includes combination approaches with targeted therapies and immunotherapy agents.
Lung Cancer Studies
The investigator conducts research in non-small cell lung cancer (NSCLC), with particular expertise in molecularly targeted approaches for specific genetic alterations.
- RET fusion-positive NSCLC
- Advanced and metastatic disease
- Immunotherapy combinations
Treatment strategies include both early-stage adjuvant therapy and advanced disease management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.